Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Anal Canal”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)UnknownNCT02560298
What this trial is testing

Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Squamous Cell Carcinoma+4 more
ECOG-ACRIN Cancer Research Group 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Not applicableNot Yet RecruitingNCT07059442
What this trial is testing

Screening for Anal Cancer and Precancer in Women With HIV (SANCA)

Who this might be right for
Anal Canal Cancer
Karolinska Institutet 1,000
Testing effectiveness (Phase 2)Study completedNCT05060471
What this trial is testing

PD-1 Blockade Combined with Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

Who this might be right for
Anal Canal CancerAnal Squamous Cell CarcinomaAnal Cancer+3 more
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03403465
What this trial is testing

Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers

Who this might be right for
Cancer of the CervixVulvar CancerEsophageal Cancer+1 more
Duke University 90
Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)UnknownNCT05374252
What this trial is testing

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Who this might be right for
Anal Canal Cancer Stage IIIAnal Squamous Cell CarcinomaAnal Canal Cancer+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT02701088
What this trial is testing

Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life

Who this might be right for
Locally Advanced Anal Canal Cancer
Centre Francois Baclesse 71
Testing effectiveness (Phase 2)Looking for participantsNCT05040815
What this trial is testing

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

Who this might be right for
Anal Canal Cancer
AHS Cancer Control Alberta 45
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT02185443
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Who this might be right for
Liver MetastasesColorectal CancerAnal Canal Cancer+1 more
University of Sao Paulo 43
Testing effectiveness (Phase 2)Study completedNCT03946358
What this trial is testing

Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckAnal Canal CancerCervical Cancer
Centre Hospitalier Universitaire de Besancon 47
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02314169
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

Who this might be right for
Anal Canal Squamous Cell CarcinomaMetastatic Anal Canal CarcinomaStage IV Anal Cancer AJCC v8
National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT01941966
What this trial is testing

Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.

Who this might be right for
Anal Canal Cancer.
Instituto do Cancer do Estado de São Paulo 51
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT01845779
What this trial is testing

Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal

Who this might be right for
Metastatic Anal Canal CancerHuman Papillomavirus
Centre Hospitalier Universitaire de Besancon 64
Load More Results